Skip to main content
logo
Jamjoom Pharmaceuticals Factory Company (TADAWUL:4015)
Saudi Arabia flag Saudi Arabia · Delayed Price · Currency is SAR
128.00
-1.30 (-1.01%)
At close: Mar 3, 2026

TADAWUL:4015 Ratios and Metrics

Millions SAR. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Mar '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Market Capitalization
8,98810,6548,050---
Market Cap Growth
-20.05%32.35%----
Enterprise Value
8,82210,5347,954---
Last Close Price
128.40146.85108.69---
PE Ratio
20.0929.8827.53---
Forward PE
17.4725.6125.41---
PS Ratio
6.178.087.31---
PB Ratio
5.447.155.73---
P/TBV Ratio
5.497.205.79---
P/FCF Ratio
28.8451.6032.10---
P/OCF Ratio
25.0640.4627.20---
PEG Ratio
-1.601.01---
EV/Sales Ratio
6.067.997.23---
EV/EBITDA Ratio
16.8624.8223.28---
EV/EBIT Ratio
18.3327.1625.19---
EV/FCF Ratio
28.3151.0231.72---
Debt / Equity Ratio
0.000.000.000.000.000.08
Debt / EBITDA Ratio
0.010.000.010.010.010.34
Debt / FCF Ratio
0.010.010.010.020.020.86
Net Debt / Equity Ratio
-0.10-0.17-0.20-0.12-0.12-0.13
Net Debt / EBITDA Ratio
-0.33-0.61-0.84-0.54-0.72-0.56
Net Debt / FCF Ratio
-0.53-1.26-1.15-1.01-1.47-1.40
Asset Turnover
0.750.770.720.650.500.58
Inventory Turnover
2.131.982.182.441.972.99
Quick Ratio
3.133.653.584.163.902.90
Current Ratio
4.185.105.045.425.063.54
Return on Equity (ROE)
28.89%24.63%22.32%14.00%14.16%18.40%
Return on Assets (ROA)
14.86%14.15%12.89%10.67%7.93%10.79%
Return on Invested Capital (ROIC)
29.27%30.80%26.73%20.71%16.05%22.25%
Return on Capital Employed (ROCE)
26.60%24.70%21.40%18.90%14.40%19.10%
Earnings Yield
4.98%3.35%3.63%---
FCF Yield
3.47%1.94%3.12%---
Dividend Yield
2.37%2.08%2.30%---
Payout Ratio
54.14%60.87%23.94%86.85%66.40%43.83%
Buyback Yield / Dilution
----600.00%--
Total Shareholder Return
2.29%2.08%2.30%-600.00%--
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.